Technology area: Biotechnology & Pharmaceuticals
268 pending office actions • 125 art units • 238 examiners • 0 of 268 (0%) have an AI response strategy ready • 164 patents granted in the last 365 days
The Board of Regents of the University of Texas System has 275 pending office actions in Biotechnology & Pharmaceuticals. The docket spans 245 distinct examiners and 131 distinct art units, creating broad examiner coverage and repeated placement within the same technical units. The scale supports centralized portfolio controls for disclosures, claim strategy, deadlines, and recurring biotechnology issues.
ROBINSON, MIKHAIL O'DONNEL is the busiest examiner, with 3 pending matters. That assignment is small relative to the full docket, so the portfolio does not turn on one examiner relationship. Art-unit-level review may provide more consistent operational insight, while each application still requires tailored treatment of biological subject matter, written-description concerns, and prosecution history.
Based on the USPTO statutory response window for each pending office action. 90 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 90 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 5 (2%) |
| §101 + other | 22 (8%) |
| §103 only | 58 (22%) |
| §102 only | 6 (2%) |
| §112 only | 23 (9%) |
| Double-patenting only | 7 (3%) |
| Double-patenting + other | 20 (7%) |
| Multi-statute (no §101) | 122 (46%) |
| No statute on record | 5 (2%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROBINSON, MIKHAIL O'DONNEL | 3 | 58.3% | +43.1% |
| HAM, JIEUN | 3 | 45.5% | +0.0% |
| QIAN, CELINE X | 3 | 47.5% | +17.2% |
| SHOMER, ISAAC | 3 | 63.1% | +30.5% |
| CHONG, KIMBERLY | 3 | 72.3% | +13.1% |
| MCCORMACK, JASON L | 2 | 84.7% | +8.1% |
| AULAKH, CHARANJIT | 2 | 80.7% | -14.5% |
| KNIGHT, TERESA E | 2 | 66.1% | +48.1% |
| MOU, LIYUAN | 2 | 43.8% | +59.9% |
| SEAMAN, D MARGARET M | 2 | 76.6% | +8.1% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18895633 | OPERANDO SCANNING ELECTRON MICROSCOPY PLATFORM AND METHODS OF USING THE SAME | MCCORMACK, JASON L | — |
| 18789936 | COLLECTION PROBE AND METHODS FOR THE USE THEREOF | MCCORMACK, JASON L | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17755881 | NATURAL KILLER CELL IMMUNOTHERAPY FOR THE TREATMENT OF GLIOBLASTOMA AND OTHER CANCERS | EBBINGHAUS, BRIANA NOEL | 217d overdue |
| 18308921 | PROACTIVE SEISMIC REHABILITATION OF WATER PIPE NETWORKS FOR EQUITABLE RECOVERY | ABOUZAHRA, REHAM K | 146d overdue |
| 18696620 | TOOL AND PROCESSES FOR PICK-AND-PLACE ASSEMBLY | KOCH, GEORGE R | 126d overdue |
| 18010456 | PROCESSES AND APPLICATIONS FOR CATALYST INFLUENCED CHEMICAL ETCHING | PETERSON, ERIK T | 84d overdue |
| 18069796 | ENCAPSULATION OF BIOACTIVE INGREDIENTS BY MULTIPLEX EMULSION | STEINKE, SEAN JAMES | 73d overdue |
| 18018350 | SOLIDS ANALYSIS OF DRILLING AND COMPLETION FLUIDS | CULLER, JILL E | 72d overdue |
| 18287009 | Synthesis of Antimicrobial PVP-coated Bismuth Nanoparticles | SHOMER, ISAAC | 71d overdue |
| 17222924 | SYSTEM AND METHOD FOR HUMAN ACTION RECOGNITION AND INTENSITY INDEXING FROM VIDEO STREAM USING FUZZY ATTENTION MACHINE LEARNING | SMITH, KEVIN LEE | 66d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18287009 | Synthesis of Antimicrobial PVP-coated Bismuth Nanoparticles | SHOMER, ISAAC | 71d overdue |
| 17782976 | EXOSOMES-BASED THERAPY FOR LIVER FIBROSIS AND OTHER DISEASES WITH FIBROSIS | CHONG, KIMBERLY | 66d overdue |
| 17929013 | METHODS FOR RAPID CLONING AND EXPRESSION OF HLA CLASS I CELLS | QIAN, CELINE X | 51d overdue |
| 17604560 | COMPOUNDS AGAINST CANCER BEARING TYROSINE KINASE INHIBITOR RESISTANT EGFR MUTATIONS | ROBINSON, MIKHAIL O'DONNEL | 12d |
| 18944707 | INDOLINONE DERIVATIVES AS INHIBITORS OF MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE | ROBINSON, MIKHAIL O'DONNEL | — |
| 18789888 | BIOCHEMICAL AND BIOMECHANICAL CONDITIONING FOR ENHANCING PERSONALIZED MESENCHYMAL STEM CELL THERAPIES | KNIGHT, TERESA E | — |
| 18787216 | INHIBITORS OF MUTANT IDH1 AND IDH2 | ROBINSON, MIKHAIL O'DONNEL | — |
| 18683988 | CRISPR-ASSOCIATED TRANSPOSONS AND USES THEREOF | QIAN, CELINE X | — |
| Art Unit | Apps |
|---|---|
| 1636 | 8 |
| 1637 | 7 |
| 1618 | 7 |
| 1621 | 6 |
| 1643 | 6 |
| 1612 | 6 |
| 1682 | 6 |
| 3798 | 5 |
| 1615 | 5 |
| 1625 | 5 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19145173 | SYSTEM AND METHODS FOR FIBER-BASED LASER SPECKLE IMAGING | CAMARGO, MARLY S.B. | 2638 | §102§103§112Other | Non-Final OA | — | Pending | Jul 01, 2025 |
| 19182434 | MODIFIED PLANTS CONTAINING COMBINATION OF APYRASE GENES AND METHOD FOR MAKING MODIFIED PLANTS WITH COMBINATION OF APYRASE GENES | LOGSDON, CHARLES | 1662 | §102§103DP | Non-Final OA | — | Pending | Apr 17, 2025 |
| 19173135 | SYSTEM AND METHOD FOR AUTOMATED ANALYSIS AND DETECTION OF CARDIAC ARRHYTHMIAS FROM ELECTROCARDIOGRAMS | HODGE, LAURA NICOLE | 3792 | §101§103Other | Non-Final OA | — | Pending | Apr 08, 2025 |
| 19106482 | AQUEOUS NANOBUBBLE DISPERSION AND GAS SUPERSATURATION AT ELEVATED PRESSURES | LEFF, ANGELA MARIE DITRAN | 3674 | §102§103 | Final Rejection | — | Pending | Feb 25, 2025 |
| 19045950 | APPARATUS FOR GENERATING THERAPEUTIC SHOCKWAVES AND APPLICATIONS OF SAME | BRUCE, FAROUK A | 3797 | Other | Non-Final OA | 8d | Pending | Feb 05, 2025 |
| 19014996 | Modular, Multicell, and Multilevel Inverter | NASH, GARY A | 2838 | §102 | Non-Final OA | — | Pending | Jan 09, 2025 |
| 19011283 | SYSTEMS AND METHODS TO REDUCE THE DC LINK CAPACITANCE AND IMPROVE THE RELIABILITY OF CONVERTERS | TORRES-RIVERA, ALEX | 2838 | §102§103§112 | Non-Final OA | — | Pending | Jan 06, 2025 |
| 18984124 | PHOTOACTIVATABLE NANOPARTICLES AND USES THEREOF AS AGENTS FOR IMMUNOTHERAPY COMBINATIONS | KAMM, JUDITH MARIE | 1611 | §103§112DP | Non-Final OA | — | Pending | Dec 17, 2024 |
| 18874393 | VIRTUAL REMOTE TELE-PHYSICAL EXAMINATION SYSTEMS | VILLECCO, JOHN M | 2661 | §103 | Non-Final OA | — | Pending | Dec 12, 2024 |
| 18976134 | Holistic and Sustainable Computing Framework for AI-Enabled Health Applications | FANG, MICHAEL YIMING | 3798 | §103 | Non-Final OA | — | Pending | Dec 10, 2024 |
| 18959959 | METHODS, SYSTEMS, AND DEVICES FOR PAIRING VAGUS NERVE STIMULATION WITH MOTOR THERAPY IN PATIENT WHO HAS HEMIPARESIS | FAIRCHILD, MALLIKA DIPAYAN | 3792 | DP | Non-Final OA | — | Pending | Nov 26, 2024 |
| 18868020 | COMPOSITE MATERIALS AND METHODS OF MAKING AND USE THEREOF | JONES, JAMES | 2872 | §102 | Non-Final OA | — | Pending | Nov 21, 2024 |
| 18949196 | SYSTEMS FOR CYBER-PHYSICAL PASSPORTS AND RELATED METHODS | TORRICO-LOPEZ, ALAN | 3625 | §101§102§103 | Non-Final OA | — | Pending | Nov 15, 2024 |
| 18866377 | ORTHOPEDIC BALL TIP GUIDEWIRE POSITIONING DEVICE | RAMANA, ANURADHA | 3775 | §103§112 | Final Rejection | 16d overdue | Pending | Nov 15, 2024 |
| 18866314 | DUST MITIGATING NANOTEXTURE AND METHOD OF MAKING | MULVANEY, ELIZABETH EVANS | 1785 | §102§103§112 | Non-Final OA | — | Pending | Nov 15, 2024 |
| 18944707 | INDOLINONE DERIVATIVES AS INHIBITORS OF MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE | ROBINSON, MIKHAIL O'DONNEL | 1627 | §101§103 | Non-Final OA | — | Pending | Nov 12, 2024 |
| 18938730 | IMIDAZOPIPERAZINE INHIBITORS OF TRANSCRIPTION ACTIVATING PROTEINS | JACKSON, SHAWQUIA | 1626 | DP | Non-Final OA | — | Pending | Nov 06, 2024 |
| 18863510 | SYSTEMS AND METHODS FOR IMPROVED TRANSPORT AND DISTRIBUTION OF AGENTS IN AND CHARACTERIZATION OF BIOLOGICAL TISSUE | SHAFQAT, AMY JEANETTE | 3798 | §102§103 | Non-Final OA | — | Pending | Nov 06, 2024 |
| 18932270 | CABLE DESIGN FOR ALL-ELECTRIC AIRCRAFT | MCALLISTER, MICHAEL F | 2847 | §102 | Non-Final OA | — | Pending | Oct 30, 2024 |
| 18860838 | AN EFFICIENT APPROACH TO OPTIMAL EXPERIMENTAL DESIGN FOR MAGNETIC RESONANCE FINGERPRINTING WITH B-SPLINES | TCHATCHOUANG, CARL F.R. | 2858 | §101§112 | Final Rejection | — | Pending | Oct 28, 2024 |
| 18860871 | A DILATING AND STENTING ORAL OR NASOPHARYNGEAL AIRWAY | MURPHY, VICTORIA | 3785 | §102§103§112 | Non-Final OA | — | Pending | Oct 28, 2024 |
| 18860498 | CONTINUOUS BLOOD FLOW VISUALIZATION WITH LASER SPECKLE CONTRAST IMAGING | LI, JOHN DENNY | 3798 | §103 | Final Rejection | 14d | Pending | Oct 25, 2024 |
| 18859101 | MICRONEEDLE-BASED PLANT SENSORS AND METHODS OF MAKING AND USING THEREOF | TRAN, VIVIAN AILINH | 1794 | §102§103§112 | Non-Final OA | — | Pending | Oct 22, 2024 |
| 18858186 | REAL-TIME BREATH ADAPTIVE NEBULIZER APPARATUS AND METHODS FOR PULMONARY THERAPEUTIC AGENT DELIVERY | ALBERS, KEVIN S | 3786 | §103§112 | Non-Final OA | — | Pending | Oct 18, 2024 |
| 18857661 | MAGNETICALLY STEERABLE CATHETER | KOLKIN, ADAM D. | 3798 | §103 | Non-Final OA | 7d | Pending | Oct 17, 2024 |
| 18911910 | Gallium-Oxide-On-Silicon (GaOxS) | FERNANDES, ERROL V | 2893 | §102§103 | Non-Final OA | — | Pending | Oct 10, 2024 |
| 18911658 | SOLID-STATE SILVER SORBENTS FOR OLEFIN ADSORPTION | ROBINSON, RENEE E | 1772 | §103 | Non-Final OA | — | Pending | Oct 10, 2024 |
| 18911908 | ISOTOPOLOGUE MARKER FOR FLUID RESOURCES OR POLLUTANTS | HINES, LATOSHA D | 1771 | §103 | Non-Final OA | — | Pending | Oct 10, 2024 |
| 18852934 | HIGH FIDELITY MIXED REALITY SYSTEM FOR MANAGING PHANTOM PAIN | AHN, CHRISTINE YERA | 2615 | §102§103 | Non-Final OA | — | Pending | Sep 30, 2024 |
| 18895633 | OPERANDO SCANNING ELECTRON MICROSCOPY PLATFORM AND METHODS OF USING THE SAME | MCCORMACK, JASON L | 2881 | §112 | Non-Final OA | — | Pending | Sep 25, 2024 |
| 18849399 | METHODS OF PREPARING CARRIER-BASED DRY POWDERS FOR INHALATION | PALENIK, JEFFREY T | 1615 | §103 | Non-Final OA | — | Pending | Sep 20, 2024 |
| 18843651 | METHODS OF TREATING CANCER WITH IAP ANTAGONIST COMPOUNDS AND COMBINATION THERAPIES | AULAKH, CHARANJIT | 1621 | §102§103 | Non-Final OA | — | Pending | Sep 03, 2024 |
| 18818538 | TUNED MATERIALS, TUNED PROPERTIES, AND TUNABLE DEVICES FROM ORDERED OXYGEN VACANCY COMPLEX OXIDES | KIM, JAY C | 2815 | §112 | Non-Final OA | — | Pending | Aug 28, 2024 |
| 18811575 | PHOSPHONIUM-BEARING CONJUGATED POLYELECTROLYTES | OH, TAYLOR V | 1625 | §112 | Non-Final OA | — | Pending | Aug 21, 2024 |
| 18799303 | PTPN11 INHIBITORS | WARD, PAUL V | 1622 | DP | Non-Final OA | — | Pending | Aug 09, 2024 |
| 18789936 | COLLECTION PROBE AND METHODS FOR THE USE THEREOF | MCCORMACK, JASON L | 2881 | §103DP | Non-Final OA | — | Pending | Jul 31, 2024 |
| 18790675 | DIGITAL LIGHT FOUR-DIMENSIONAL PRINTING OF PROGRAMMABLE MORPHOLOGY AND MOTION STRUCTURES | LIANG, ANTHONY M | 1734 | §112 | Non-Final OA | — | Pending | Jul 31, 2024 |
| 18789888 | BIOCHEMICAL AND BIOMECHANICAL CONDITIONING FOR ENHANCING PERSONALIZED MESENCHYMAL STEM CELL THERAPIES | KNIGHT, TERESA E | 1634 | DP | Non-Final OA | — | Pending | Jul 31, 2024 |
| 18787216 | INHIBITORS OF MUTANT IDH1 AND IDH2 | ROBINSON, MIKHAIL O'DONNEL | 1627 | §112 | Non-Final OA | — | Pending | Jul 29, 2024 |
| 18833989 | ATTENUATED SARS-COV-2 | HILL, MYRON G | 1648 | §102§103 | Non-Final OA | — | Pending | Jul 29, 2024 |
| 18728885 | HIGH-PRECISION HETEROGENEOUS INTEGRATION | JOHNSON, CHRISTOPHER A | 2899 | §102§103§112 | Non-Final OA | — | Pending | Jul 14, 2024 |
| 18728323 | METHODS AND SYSTEMS FOR DETERMINING LEUKEMIA OR LYMPHOMA LEVELS USING LYMPHOID IMAGES | JOHNSON, NICOLE F | 3796 | §103 | Final Rejection | 8d | Pending | Jul 11, 2024 |
| 18766484 | SYNTHESIS AND FABRICATION OF MECHANICALLY ROBUST AND MESOPOROUS ABAC TETRABLOCK POLYMER MEMBRANES FOR ULTRAFILTRATION | EZELUOMBA, MIRIAM NCHEKWUBECHU | 1776 | §102§103§112 | Non-Final OA | — | Pending | Jul 08, 2024 |
| 18763115 | APPARATUS AND METHODS FOR COMPUTATIONALLY INFORMED ADHESION MEASUREMENT USING THE BLISTER TEST | DEVITO, ALEX T | 2855 | §102§103 | Non-Final OA | — | Pending | Jul 03, 2024 |
| 18725495 | POTENT AND SELECTIVE SMARCA2 DEGRADING CHIMERIC MOLECULES AS CANCER THERAPEUTICS | HEITMEIER, KENDALL NICOLE | 1621 | §103§112 | Non-Final OA | — | Pending | Jun 28, 2024 |
| 18757031 | INTEGRATED ELECTRODE AND CABLE STRUCTURE | AZAM, MUHAMMED | 2847 | §102§103§112 | Non-Final OA | — | Pending | Jun 27, 2024 |
| 18722475 | ENDOSCOPIC TUBULAR MINIMALLY INVASIVE SURGICAL SYSTEM | LONDON, STEPHEN FLOYD | 3795 | §102§103§112 | Final Rejection | 29d overdue | Pending | Jun 20, 2024 |
| 18719116 | REVERSAL OF SENESCENCE BY ULTRASOUND IRRADIATION | CWERN, JONATHAN | 3797 | §102§103 | Non-Final OA | — | Pending | Jun 12, 2024 |
| 18717529 | PHARMACEUTICAL COMBINATION COMPRISING ABEMACICLIB AND A PI3K AND/OR A MTOR INHIBITOR FOR THE TREATMENT OF MANTLE CELL LYMPHOMA | VISHNYAKOVA, ELENA VLADIMIROVNA | — | §102§103§112 | Non-Final OA | — | Pending | Jun 07, 2024 |
| 18716052 | GLUCOCORTICOID RECEPTOR BLOCKADE WITH MIFEPRISTONE TO SENSITIZE PANCREATIC CANCER TO IMMUNOTHERAPY | AULAKH, CHARANJIT | 1621 | §102§103§112 | Non-Final OA | — | Pending | Jun 03, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBoard of Regents of the University of Texas System has 268 pending office actions as of October 2026, spread across 125 art units and 238 examiners.
Mikhail O'Donnel Robinson has the most, with 3 of Board of Regents of the University of Texas System's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
